PT Kimia Farma Tbk (IDX:KAEF)

Theseus Pharmaceuticals Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	251,232	437,589	783,531	2,191,075	748,481	1,249,994
Cash & Short-Term Investments	251,232	437,589	783,531	2,191,075	748,481	1,249,994
Cash Growth	-18.71%	-44.15%	-64.24%	192.74%	-40.12%	-8.11%
Accounts Receivable	1,342,919	1,165,266	1,619,842	1,829,080	1,943,935	1,526,705
Other Receivables	228,752	-	-	-	-	-
Receivables	1,571,671	1,352,385	1,872,770	2,349,408	2,193,497	1,760,955
Inventory	1,561,416	1,504,022	2,132,277	2,941,267	2,690,960	2,537,932
Prepaid Expenses	30,578	18,204	47,710	87,506	53,799	114,512
Restricted Cash	234,960	231,949	-	-	-	-
Other Current Assets	409,704	388,502	372,395	610,548	514,026	429,712
Total Current Assets	4,059,560	3,932,652	5,208,682	8,179,803	6,200,763	6,093,104
Property, Plant & Equipment	9,491,935	9,557,854	9,862,608	10,088,554	9,974,355	9,994,751
Long-Term Investments	19,418	19,418	166,002	166,002	166,010	166,010
Goodwill	53,678	53,678	107,555	134,444	134,444	134,444
Other Intangible Assets	56,057	57,031	96,519	60,428	59,527	54,649
Long-Term Deferred Tax Assets	179,768	176,960	109,788	78,039	102,066	66,152
Long-Term Deferred Charges	-	-	-	11,066	29,579	25,781
Other Long-Term Assets	1,165,799	1,169,145	1,079,253	1,076,083	1,087,056	1,022,886
Total Assets	15,026,460	14,967,031	16,630,699	19,797,323	17,760,195	17,562,817
Accounts Payable	1,748,965	1,738,783	1,967,139	1,468,466	786,453	1,288,288
Accrued Expenses	1,090,711	1,176,009	643,588	366,215	244,841	170,908
Short-Term Debt	2,153,531	3,365,625	5,646,479	4,304,587	3,631,865	4,379,678
Current Portion of Long-Term Debt	1,089,538	1,432,275	1,642,061	2,073,812	1,110,037	772,205
Current Portion of Leases	6,325	28,278	25,702	30,518	33,284	15,574
Current Income Taxes Payable	-	46,481	61,101	59,548	73,587	41,339
Other Current Liabilities	589,182	161,105	153,250	388,118	100,113	118,950
Total Current Liabilities	6,678,251	7,948,557	10,139,321	8,691,264	5,980,181	6,786,942
Long-Term Debt	3,878,251	2,653,969	762,973	1,666,078	3,209,731	2,563,153
Long-Term Leases	86,657	70,670	15,924	38,930	39,023	30,334
Long-Term Deferred Tax Liabilities	80,827	80,827	89,943	489,567	414,647	438,131
Total Liabilities	11,604,156	11,538,223	11,852,459	11,794,567	10,528,322	10,457,145
Common Stock	556,659	556,659	556,649	555,400	555,400	555,400
Additional Paid-In Capital	-882,526	-	-	-	-	-
Retained Earnings	-2,820,174	-3,108,649	-2,320,314	996,093	2,586,455	2,291,237
Comprehensive Income & Other	6,625,792	5,978,732	6,190,746	5,586,139	3,997,789	4,146,760
Total Common Equity	3,479,751	3,426,741	4,427,081	7,137,633	7,139,643	6,993,397
Minority Interest	-57,446	2,068	351,159	865,123	92,229	112,275
Shareholders' Equity	3,422,304	3,428,809	4,778,240	8,002,756	7,231,873	7,105,672
Total Liabilities & Equity	15,026,460	14,967,031	16,630,699	19,797,323	17,760,195	17,562,817
Total Debt	7,214,302	7,550,817	8,093,138	8,113,925	8,023,941	7,760,945
Net Cash (Debt)	-6,963,070	-7,113,228	-7,309,607	-5,922,851	-7,275,459	-6,510,951
Net Cash Per Share	-	-1277.85	-1314.22	-1065.04	-1309.95	-1172.30
Filing Date Shares Outstanding	-	5,567	5,562	5,554	5,554	5,554
Total Common Shares Outstanding	-	5,567	5,562	5,554	5,554	5,554
Working Capital	-2,618,691	-4,015,905	-4,930,638	-511,461	220,583	-693,838
Book Value Per Share	-	615.59	795.90	1285.13	1285.50	1259.16
Tangible Book Value	3,370,016	3,316,032	4,223,007	6,942,761	6,945,673	6,804,304
Tangible Book Value Per Share	-	595.70	759.21	1250.05	1250.57	1225.12
Land	-	6,677,793	6,710,022	6,707,160	6,336,240	6,270,047
Buildings	-	1,778,536	1,739,322	1,576,431	1,530,320	537,036
Machinery	-	2,613,888	2,528,145	2,364,451	2,303,239	1,705,555
Construction In Progress	-	100,177	198,944	789,219	432,279	2,246,848
Leasehold Improvements	-	1,146,195	1,062,134	196,118	513,872	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.